US faith-based group leads 'near-shoring' Abraham Accords push to open regional FDA office with bipartisan support in Washington, but health agencies yet to give public backing

Human tests expected within a year; inventor says approach has potential for many viruses, including influenza, Zika, West Nile, and hepatitis B

Undetected problems with treatment regimens land many elderly patients in hospital; artificial intelligence system that sounds an alarm is built in Tel Aviv, deployed by Leumit HMO

Prospective medication seeks to tweak gut germs in patients who don't respond well to treatment, utilizing research that suggests microbiome impacts effectiveness

Syringe with peptides and protein fragments developed by Israel's Mileutis to stimulate immune system and reduce use of antibiotics; investor is US-based NovaQuest

ImmunoBrain Checkpoint's antibody that boosts immune cells' communication with brain seen effective in lab animals; clinical trials in humans to start next year

Biosimilars are generic versions of biopharmaceutical drugs; Iceland's Alvotech will develop and supply the biosimilars and Teva will exclusively commercialize them in the US

Firm announces R&D partnerships with Weizmann Institute, Tel Aviv University in brain and cancer therapies; move marks foray into 'merging of minds between academia and pharma'

DSP-107, developed by KAHR Medical, hopes to have dual impact: tag cancer cells, and boost activity of the immune cells that target them